Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors.

Gokce M, Altan I, Unal S, Kuskonmaz B, Aytac S, Cetin M, Tuncer M, Gumruk F, Gurgey A.

Blood Coagul Fibrinolysis. 2012 Jul;23(5):434-9. doi: 10.1097/MBC.0b013e3283548e39.

PMID:
22610137
2.

Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children.

Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ; Mountain States Regional Thrombophilia Group.

N Engl J Med. 2004 Sep 9;351(11):1081-8. Erratum in: N Engl J Med. 2005 May 19;352(20):2146.

3.

Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.

Palareti G, Legnani C, Cosmi B, Valdré L, Lunghi B, Bernardi F, Coccheri S.

Circulation. 2003 Jul 22;108(3):313-8. Epub 2003 Jul 7.

4.

Pulmonary thromboembolism in childhood: a single-center experience from Turkey.

Tavil B, Kuskonmaz B, Kiper N, Cetin M, Gumruk F, Gurgey A.

Heart Lung. 2009 Jan-Feb;38(1):56-65. doi: 10.1016/j.hrtlng.2007.06.004. Epub 2008 Aug 23.

PMID:
19150531
5.

Nonstroke arterial thrombosis in children: Hacettepe experience.

Balci YI, Unal S, Gumruk F, Cetin M, Ozkutlu S, Gurgey A.

Blood Coagul Fibrinolysis. 2008 Sep;19(6):519-24. doi: 10.1097/MBC.0b013e328304e01d.

PMID:
18685435
6.

Pediatric stroke among Hong Kong Chinese subjects.

Chung B, Wong V.

Pediatrics. 2004 Aug;114(2):e206-12.

PMID:
15286258
7.
8.

Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors.

Nowak-Göttl U, Junker R, Kreuz W, von Eckardstein A, Kosch A, Nohe N, Schobess R, Ehrenforth S; Childhood Thrombophilia Study Group.

Blood. 2001 Feb 15;97(4):858-62.

9.

D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.

Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M.

J Thromb Haemost. 2006 Jun;4(6):1208-14.

10.

Deep venous thrombosis in children and adolescents.

Levy ML, Granville RC, Hart D, Meltzer H.

J Neurosurg. 2004 Aug;101(1 Suppl):32-7.

PMID:
16206969
11.

Recurrent venous thromboembolism in a Spanish population: incidence, risk factors, and management in a hospital setting.

Grau E, Real E, Medrano J, Pastor E, Selfa S.

Thromb Res. 1999 Dec 1;96(5):335-41.

PMID:
10605948
12.

Venous thromboembolism in pediatric patients: epidemiologic data from a pediatric tertiary care center in Alabama.

Wright JM, Watts RG.

J Pediatr Hematol Oncol. 2011 May;33(4):261-4. doi: 10.1097/MPH.0b013e3182134111.

PMID:
21516021
13.

Cardiac transplant in a child with recurrent thrombosis due to congenital thrombophilic mutations.

Ozkan S, Atac FB, Ozcobanoglu S, Uguz E, Sezgin A, Verdi H, Ozbek N, Aslamaci S.

Exp Clin Transplant. 2009 Sep;7(3):188-91.

14.

Outcome after kidney transplantation in children with thrombotic risk factors.

Kranz B, Vester U, Nadalin S, Paul A, Broelsch CE, Hoyer PF.

Pediatr Transplant. 2006 Nov;10(7):788-93.

PMID:
17032424
15.

The management of thrombosis in the antiphospholipid-antibody syndrome.

Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR.

N Engl J Med. 1995 Apr 13;332(15):993-7.

16.

Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.

Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S.

Thromb Haemost. 2002 Jan;87(1):7-12.

PMID:
11848459
17.

Cerebral venous congestion as indication for thrombolytic treatment.

Tsai FY, Kostanian V, Rivera M, Lee KW, Chen CC, Nguyen TH.

Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):675-87.

PMID:
17573553
18.

[A new thrombophilia risk factor: the increase of plasma factor VIII].

Hernández-Jerónimo J, Pérez-Campos E, Matadamas C, Majluf-Cruz A.

Rev Invest Clin. 2003 Jul-Aug;55(4):448-57. Review. Spanish.

PMID:
14635611
19.

Clinical experience with recombinant tissue plasminogen activator in the management of intracardiac and arterial thrombosis in children.

Olgun H, Buyukavci M, Ceviz N, Sahin IO, Yildirim ZK, Colak A, Tekgunduz KS, Caner I.

Blood Coagul Fibrinolysis. 2014 Oct;25(7):726-30. doi: 10.1097/MBC.0000000000000134.

PMID:
24806322
20.

A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.

Krnic-Barrie S, O'Connor CR, Looney SW, Pierangeli SS, Harris EN.

Arch Intern Med. 1997 Oct 13;157(18):2101-8.

PMID:
9382667

Supplemental Content

Support Center